Two dose levels of ifosfamide in malignant mesothelioma
- 30 September 1996
- journal article
- clinical trial
- Published by Elsevier in Lung Cancer
- Vol. 15 (2) , 207-213
- https://doi.org/10.1016/0169-5002(96)00584-3
Abstract
No abstract availableKeywords
This publication has 6 references indexed in Scilit:
- A phase II evaluation of ifosfamide and mesna in unresectable diffuse malignant mesothelioma: A southwest oncology group studyCancer, 1992
- Malignant Pleural Mesothelioma Due to Environmental Mineral Fiber Exposure in TurkeyChest, 1992
- Chemotherapy in malignant mesothelioma: a reviewCancer Chemotherapy and Pharmacology, 1991
- Diagnosis and treatment of pleural mesotheliomaSeminars in Surgical Oncology, 1990
- Malignant Pleural Mesothelioma: Phase II Pilot Study of Ifosfamide and Mesna*JNCI Journal of the National Cancer Institute, 1988
- Nonparametric Estimation from Incomplete ObservationsJournal of the American Statistical Association, 1958